Two Sigma Securities, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Two Sigma Securities, LLC

  • $716 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.22 - $0.42 $18,088 - $34,532
-82,220 Reduced 80.6%
19,796 $4,000
Q2 2024

Aug 14, 2024
BUY
$0.34 - $0.74 $34,685 - $75,491
102,016 New
102,016 $34,000
Q3 2023

Nov 14, 2023
BUY
$0.2 - $2.08 $8,055 - $83,780
40,279 New
40,279 $8,000

Others Institutions Holding BCLI

# of Institutions
22
Shares Held
7.81M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $65.3M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email